7.19
price down icon3.46%   -0.33
 
loading
Precedente Chiudi:
$7.52
Aprire:
$7.4
Volume 24 ore:
112.93K
Relative Volume:
0.11
Capitalizzazione di mercato:
$555.85M
Reddito:
$11.40B
Utile/perdita netta:
$-95.73M
Rapporto P/E:
-3.6131
EPS:
-1.99
Flusso di cassa netto:
$-64.37M
1 W Prestazione:
-13.47%
1M Prestazione:
+12.04%
6M Prestazione:
-13.00%
1 anno Prestazione:
+170.90%
Intervallo 1D:
Value
$7.23
$7.58
Intervallo di 1 settimana:
Value
$6.70
$9.85
Portata 52W:
Value
$2.69
$12.22

Mind Medicine Inc Stock (MNMD) Company Profile

Name
Nome
Mind Medicine Inc
Name
Telefono
212-220-6633
Name
Indirizzo
ONE WORLD TRADE CENTER, NEW YORK
Name
Dipendente
57
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
MNMD's Discussions on Twitter

Confronta MNMD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
MNMD 7.23 555.85M 11.40B -95.73M -64.37M -1.99
VRTX 447.12 115.74B 10.63B -479.80M -1.35B 13.33
REGN 740.36 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 590.00 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.10 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.41 24.49B 3.30B -501.07M 1.03B 11.54

Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-12-09 Ripresa ROTH Capital Buy
2022-11-16 Iniziato RBC Capital Mkts Outperform
2022-08-26 Iniziato Oppenheimer Outperform
2022-08-10 Iniziato Cantor Fitzgerald Overweight
2022-05-04 Iniziato ROTH Capital Buy
2021-06-28 Iniziato Maxim Group Buy
Mostra tutto

Mind Medicine Inc Borsa (MNMD) Ultime notizie

pulisher
02:11 AM

Analysts Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Price Target at $25.38 - MarketBeat

02:11 AM
pulisher
Nov 19, 2024

Generalized Anxiety Disorder Market to Reach New Heights - openPR

Nov 19, 2024
pulisher
Nov 19, 2024

MindMed recruits regulatory expert ahead of Phase III trials - The Pharma Letter

Nov 19, 2024
pulisher
Nov 18, 2024

MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer - BioSpace

Nov 18, 2024
pulisher
Nov 18, 2024

MindMed Appoints Former Karuna Executive to Lead Phase 3 Regulatory Strategy | MNMD Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 17, 2024

(MNMD) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Nov 17, 2024
pulisher
Nov 16, 2024

Is Mind Medicine (MNMD) the Best Multibagger Stock to Buy Heading into 2025? - Insider Monkey

Nov 16, 2024
pulisher
Nov 15, 2024

Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap UpHere's What Happened - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Stock Traders Purchase Large Volume of Call Options on Mind Medicine (MindMed) (NASDAQ:MNMD) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

COMMODORE CAPITAL LP Acquires Shares in Mind Medicine Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

10 Best Multibagger Stocks To Buy Heading into 2025 - Insider Monkey

Nov 14, 2024
pulisher
Nov 14, 2024

Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) market cap touched US$601m last week, benefiting both retail investors who own 41% as well as institutions - Yahoo Finance

Nov 14, 2024
pulisher
Nov 13, 2024

Mind Medicine Mindmed Inc (MNMD-Q) QuotePress Release - The Globe and Mail

Nov 13, 2024
pulisher
Nov 13, 2024

Can Canada’s psychedelic drug developers shake off the sector’s bad trip? - The Globe and Mail

Nov 13, 2024
pulisher
Nov 13, 2024

MindMed (MNMD) to Present at Major Healthcare Investor Conferences in London, Florida | MNMD Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 11, 2024

Mind Medicine (MindMed)'s (MNMD) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

Mind Medicine: No News = Good News (NASDAQ:MNMD) - Seeking Alpha

Nov 10, 2024
pulisher
Nov 09, 2024

Adam Stanecki on Mind Medicine with Charles Kovess11 November 2023 - imdb

Nov 09, 2024
pulisher
Nov 08, 2024

Mind Medicine Inc (MNMD) Q3 2024 Earnings Call Highlights: Strong Cash Position and Clinical ... By GuruFocus - Investing.com Canada

Nov 08, 2024
pulisher
Nov 08, 2024

Mind Medicine Inc (MNMD) Q3 2024 Earnings Call Highlights: Stron - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Mind Medicine Inc (MNMD) Q3 2024 Earnings Call Highlights: Strong Cash Position and Clinical ... - Yahoo Finance

Nov 08, 2024
pulisher
Nov 08, 2024

Mind Medicine's Triple-Digit Gains And The Recent CorrectionExcitement Or Anxiety On The Horizon? - RTTNews

Nov 08, 2024
pulisher
Nov 08, 2024

MindMed Advances Phase 3 Trials in Mental Health - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Certain Restricted Stock Units of Mind Medicine Inc. are subject to a Lock-Up Agreement Ending on 8-NOV-2024. - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Certain Common Stock of Mind Medicine Inc. are subject to a Lock-Up Agreement Ending on 8-NOV-2024. - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

MindMed Reports Third Quarter 2024 Financial Results and Business Updates - Business Wire

Nov 07, 2024
pulisher
Nov 07, 2024

Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 10.1%What's Next? - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

(MNMD) Trading Report - Stock Traders Daily

Nov 06, 2024
pulisher
Nov 04, 2024

Mind Medicine: Two Pathways Created From One Pipeline Clinical Candidate (NASDAQ:MNMD) - Seeking Alpha

Nov 04, 2024
pulisher
Oct 31, 2024

Mind Medicine (MindMed) (MNMD) to Release Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2024
pulisher
Oct 27, 2024

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat

Oct 27, 2024
pulisher
Oct 24, 2024

MNMDMind Medicine (MindMed) Inc. Common Shares Latest Stock News & Market Updates - StockTitan

Oct 24, 2024
pulisher
Oct 24, 2024

MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update - The Globe and Mail

Oct 24, 2024
pulisher
Oct 19, 2024

FDA is said to see “path forward” for ecstasy-based drug (DRUG:NASDAQ) - Seeking Alpha

Oct 19, 2024
pulisher
Oct 17, 2024

MindMed announces exchange agreement with investors By Investing.com - Investing.com

Oct 17, 2024
pulisher
Oct 16, 2024

Bright Minds rally ends as psychedelic stocks extend volatility - MSN

Oct 16, 2024
pulisher
Oct 16, 2024

Bright Minds stock cools amid psychedelic volatility (DRUG:NASDAQ) - Seeking Alpha

Oct 16, 2024
pulisher
Oct 15, 2024

(MNMD) Investment Analysis and Advice - Stock Traders Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Rating Upgraded by Leerink Partnrs - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

Mind Medicine (MindMed) (NASDAQ:MNMD) Coverage Initiated at Leerink Partners - MarketBeat

Oct 14, 2024
pulisher
Oct 12, 2024

Mind Medicine assumed with an Outperform at Leerink - Yahoo Finance

Oct 12, 2024
pulisher
Oct 05, 2024

Stroke-recovery device using brain-computer interface receives FDA market authorization | WashU Medicine - WashU Medicine

Oct 05, 2024
pulisher
Oct 05, 2024

Trend Tracker for (MNMD) - Stock Traders Daily

Oct 05, 2024
pulisher
Oct 02, 2024

"TNT Radio" Jeff Ghaemaghamy on Mind Medicine with Charles Kovess28 January 2024 (Podcast Episode 2024)News - imdb

Oct 02, 2024
pulisher
Oct 02, 2024

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Oct 02, 2024
pulisher
Oct 01, 2024

MindMed's SWOT analysis: psychedelic stock's potential in anxiety treatment - Investing.com

Oct 01, 2024
pulisher
Sep 28, 2024

Marshall Wace LLP Has $15.58 Million Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - MarketBeat

Sep 28, 2024
pulisher
Sep 26, 2024

Mind Medicine's chief medical officer sells shares worth over $41,000 - Investing.com India

Sep 26, 2024
pulisher
Sep 25, 2024

MindMed executive sells over $26k in company stock By Investing.com - Investing.com South Africa

Sep 25, 2024
pulisher
Sep 25, 2024

Mind Medicine's chief medical officer sells shares worth over $41,000 By Investing.com - Investing.com UK

Sep 25, 2024
pulisher
Sep 25, 2024

Generalized Anxiety Disorder Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, MOA, ROA by DelveInsight | Pfizer Inc., GlaxoSmithKline, Eli Lilly and Company, MindMed, VistaGen Pharma - Barchart

Sep 25, 2024

Mind Medicine Inc Azioni (MNMD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Mind Medicine Inc Azioni (MNMD) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Liao Carrie
Chief Accounting Officer
Sep 25 '24
Sale
5.98
2,352
14,065
99,543
Barrow Robert
Chief Executive Officer
Sep 25 '24
Sale
5.98
19,771
118,231
545,772
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):